Medindia

X

Quest Diagnostics to Speak at the Bank of America Merrill Lynch 2011 Healthcare Conference

Thursday, May 12, 2011 General News J E 4
Advertisement

Outlook for 2011 Before Future Special Items

As

Reported

Medi-Cal

Charge

(a)

Severe

Weather

(b)

Restructuring

Charges

(c)

Transaction

Costs

(d)

As

Adjusted

Diluted earnings per common share

$2.92- $3.12

$1.19

$0.07

$0.05

$0.02

$4.25-$4.45

Operating income as a % of net revenues

14.0%-14.5%

3.0%

0.3%

0.2%

%

17.5%-18.0%

Cash from operations

~$900

$195

(e)

(e)

(e)

~$1,100

(a) Represents the first quarter pre-tax charge of $236 million associated with the agreement in principle related to Medi-Cal.

(b) Represents an estimate of the impact of severe weather.

(c) Represents first quarter pre-tax restructuring charges of $13.3 million principally associated with workforce reductions.

(d) Represents first quarter pre-tax transaction costs of $4.7 million associated with the acquisitions of Athena Diagnostics and Celera Corporation. Of these costs, $2.3 million, primarily related to professional and filing fees, was recorded in selling, general, and administrative expenses and $2.4 million of financing related costs were recorded in interest expense, net.

(e) Not significant to the outlook for cash flows from operations.

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Valor Medical Receives CE Mark for Neucrylate AN™ ...
S
The Leukemia & Lymphoma Society's Man & Woman of t...